loading...
Distributed by Mapi Research Trust
Distributed by Mapi Research Trust
The E-versions of this instrument are distributed by Mapi Research Trust
AQLQ(S): Standardised Asthma Quality of Life Questionnaire
AQLQ +12: for patients 12 years and older
Acute AQLQ: for acute severe asthma
Juniper E
Asthma
Juniper EF, Buist AS, Cox FM et al. Validation of a standardized version of the Asthma Quality of Life Questionnaire. Chest 1999; 115: 1265-1270 (Full text article)
Juniper EF, Guyatt GH, Ferrie PJ, Griffith LE. Measuring quality of life in asthma. Am Rev Respir Dis 1993; 147: 832-838 (PubMed abstract)
Juniper EF, Guyatt GH, Epstein RS et al. Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials. Thorax 1992; 47: 76-83 (Full text article)
Specific conditions apply. Please contact QOL Technologies Ltd.
Mapi Research Trust officially and exclusively distributes all electronic versions of the questionnaires developed by Professor E. Juniper and gives permission on behalf of QOL Technologies Ltd (QOL Tech).
A license agreement must be completed and a User fee is required to all users (commercial & academic users).
More information on QOL Tech’s electronic versions
Step 1 - Firstly, QOL Technologies Ltd. (Mrs Jilly Styles - jill@qoltech.co.uk) has to be contacted in order to pay a standard one-off user fee calculated per language and per package of questionnaires (commonly called the “paper & .pdf versions”). This package includes the most frequently used versions of questionnaires, an implementation document which provides information on administration, analysis and interpretation, and some reprints that describe the development and validation of the questionnaires. Once this fee has been paid it entitles your organisation worldwide (study sponsor) to unlimited usage of the paper and .pdf versions of the questionnaire(s).
This payment is required even if you intend using the questionnaires electronically.
Step 2 - Please fill out our user agreement and return it to us by e-mail. At this stage, though you are not required to sign the form, the information in the agreement is helping us calculate the quote (access fees) and determine the work that needs to be done with Mapi Language Services. We will be pleased to contact them on your behalf to obtain a quotation for the required work in case no electronic version is available in the language you are requesting and needs to be developed.
Step 3 - If you decide to go ahead, you will be requested to sign the full study-specific user agreement and return it completed to Mapi Research Trust (e-mail and hardcopy for our records). The invoice will then be issued.
Step 4 – If/When the version is available and once your payment has been received by Mapi Research Trust, you may use (depending on your request):
If you have any question, please feel free to contact us, we will be happy to guide you through the process.
Mapi Research Trust
PROVIDE™
27 rue de la Villette
69003 Lyon
France
Phone: +33 (0)4 72 13 66 66
Specific conditions apply. Please contact QOL Technologies Ltd.
Mapi Research Trust officially and exclusively distributes all electronic versions of the questionnaires developed by Professor E. Juniper and gives permission on behalf of QOL Technologies Ltd (QOL Tech).
A license agreement must be completed and a User fee is required to all users (commercial & academic users).
More information on QOL Tech’s electronic versions
Step 1 - Firstly, QOL Technologies Ltd. (Mrs Jilly Styles - jill@qoltech.co.uk) has to be contacted in order to pay a standard one-off user fee calculated per language and per package of questionnaires (commonly called the “paper & .pdf versions”). This package includes the most frequently used versions of questionnaires, an implementation document which provides information on administration, analysis and interpretation, and some reprints that describe the development and validation of the questionnaires. Once this fee has been paid it entitles your organisation worldwide (study sponsor) to unlimited usage of the paper and .pdf versions of the questionnaire(s).
This payment is required even if you intend using the questionnaires electronically.
Step 2 - Please fill out our user agreement and return it to us by e-mail. At this stage, though you are not required to sign the form, the information in the agreement is helping us calculate the quote (access fees) and determine the work that needs to be done with Mapi Language Services. We will be pleased to contact them on your behalf to obtain a quotation for the required work in case no electronic version is available in the language you are requesting and needs to be developed.
Step 3 - If you decide to go ahead, you will be requested to sign the full study-specific user agreement and return it completed to Mapi Research Trust (e-mail and hardcopy for our records). The invoice will then be issued.
Step 4 – If/When the version is available and once your payment has been received by Mapi Research Trust, you may use (depending on your request):
If you have any question, please feel free to contact us, we will be happy to guide you through the process.
Examination copies can only be used for the limited purpose of examining the suitability of the Questionnaire for subsequent research and/or clinical use, and cannot be used in research or in clinical practice or distributed to others.
You are not authorized to modify, retype, translate, copy or otherwise duplicate the Questionnaire except with the further and prior written permission of Mapi Research Trust / the developers / copyright holders / distributors.
The listed translations may not have undergone a full linguistic validation process and may require further work to be suitable for use in a study. This list is subject to constant changes, therefore please check the status of translations with Mapi Research Trust / the developers / copyright holders / distributors.
For the most current list of languages available, please check www.qoltech.co.uk
The author has selected Mapi/ICON Language Services as exclusive linguistic validation company to ensure the production of harmonized and consistent language versions.
For additional information on available translations of this instrument, or for a project involving new languages, please submit a request (tutorials available on our FAQs).
Tan WC, Tan JW, Wee EW, Niti M, Ng TP. Validation of the English version of the Asthma Quality of Life Questionnaire in a multi-ethnic Asian population. Qual Life Res. 2004 Mar;13(2):551-6
Leroyer C, Lebrun T, Proust A, Lenne X, Lucas E, Rio G, Dewitte JD, Clavier J. Knowledge, self-management, compliance and quality of life in asthma: a cross-sectional study of the French version of the Asthma Quality of Life Questionnaire. Qual Life Res. 1998 Apr;7(3):267-72
Xu KF, Luo XC, Chen Y, Zhang YJ, Li Y, Hu B, Lu WX, Li LY, Zhu YJ. [The use of Juniper's asthma quality of life questionnaire in Chinese asthmatics] Zhonghua Nei Ke Za Zhi. 2003 Nov;42(11):760-3. Chinese
Tomic Spiric V, Bogic M, Jankovic S, Maksimovic N, Matovic Miljanovic S, Peric Popadic A, Raskovic S, Milic N. Assessment of the Asthma Quality of Life Questionnaire (AQLQ): Serbian translation. Croat Med J. 2004 Apr;45(2):188-94
Sanjuas C, Alonso J, Ferrer M, Curull V, Broquetas JM, Anto JM. Adaptation of the Asthma Quality of Life Questionnaire to a second language preserves its critical properties: the Spanish version. J Clin Epidemiol. 2001 Feb;54(2):182-9
Sanjuas C, Alonso J, Sanchis J, Casan P, Broquetas JM, Ferrie PJ, Juniper EF, Anto JM. [The quality-of-life questionnaire with asthma patients: the Spanish version of the Asthma Quality of Life Questionnaire] Arch Bronconeumol. 1995 May;31(5):219-26. Spanish
Type of Device |
e-Vendors for AQLQ(S) |
e-Vendors for AQLQ+12 |
|---|---|---|
Handheld |
CRF Health ExcoInTouch |
ERT ExcoInTouch Vitalograph |
Tablet |
CRF Health ERT (Tablet + Netguides integrated Web Service) |
ERT (Tablet + Netguides integrated Web Service) Vitalograph |
Digital Pen |
ERT |
|
Web-based |
Netguides |
Netguides |
Access to advanced descriptions of Clinical Outcome Assessments (COAs)